366 related articles for article (PubMed ID: 17214606)
1. Metabolic drug interactions with newer antipsychotics: a comparative review.
Spina E; de Leon J
Basic Clin Pharmacol Toxicol; 2007 Jan; 100(1):4-22. PubMed ID: 17214606
[TBL] [Abstract][Full Text] [Related]
2. Newer antipsychotics: comparative review of drug interactions.
Spina E; Scordo MG
Expert Rev Neurother; 2001 Nov; 1(2):171-82. PubMed ID: 19811029
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and drug interactions: update for new antipsychotics.
Ereshefsky L
J Clin Psychiatry; 1996; 57 Suppl 11():12-25. PubMed ID: 8941167
[TBL] [Abstract][Full Text] [Related]
4. New antipsychotic agents for schizophrenia: pharmacokinetics and metabolism update.
Caccia S
Curr Opin Investig Drugs; 2002 Jul; 3(7):1073-80. PubMed ID: 12186270
[TBL] [Abstract][Full Text] [Related]
5. Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents.
Murray M
J Pharm Pharmacol; 2006 Jul; 58(7):871-85. PubMed ID: 16805946
[TBL] [Abstract][Full Text] [Related]
6. Biotransformation of post-clozapine antipsychotics: pharmacological implications.
Caccia S
Clin Pharmacokinet; 2000 May; 38(5):393-414. PubMed ID: 10843459
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions.
Urichuk L; Prior TI; Dursun S; Baker G
Curr Drug Metab; 2008 Jun; 9(5):410-8. PubMed ID: 18537577
[TBL] [Abstract][Full Text] [Related]
8. Interactions between the cytochrome P450 system and the second-generation antipsychotics.
Prior TI; Baker GB
J Psychiatry Neurosci; 2003 Mar; 28(2):99-112. PubMed ID: 12670127
[TBL] [Abstract][Full Text] [Related]
9. Metabolic drug interactions with new psychotropic agents.
Spina E; Scordo MG; D'Arrigo C
Fundam Clin Pharmacol; 2003 Oct; 17(5):517-38. PubMed ID: 14703714
[TBL] [Abstract][Full Text] [Related]
10. Drug metabolism and atypical antipsychotics.
Prior TI; Chue PS; Tibbo P; Baker GB
Eur Neuropsychopharmacol; 1999 Jun; 9(4):301-9. PubMed ID: 10422890
[TBL] [Abstract][Full Text] [Related]
11. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
[TBL] [Abstract][Full Text] [Related]
12. Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia.
Vohora D
Curr Opin Investig Drugs; 2007 Jul; 8(7):531-8. PubMed ID: 17659473
[TBL] [Abstract][Full Text] [Related]
13. The dosing of atypical antipsychotics.
de Leon J; Armstrong SC; Cozza KL
Psychosomatics; 2005; 46(3):262-73. PubMed ID: 15883149
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response.
Mauri MC; Volonteri LS; Colasanti A; Fiorentini A; De Gaspari IF; Bareggi SR
Clin Pharmacokinet; 2007; 46(5):359-88. PubMed ID: 17465637
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 polymorphisms and response to antipsychotic therapy.
Scordo MG; Spina E
Pharmacogenomics; 2002 Mar; 3(2):201-18. PubMed ID: 11972442
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs.
Spina E; Perucca E
Epilepsia; 2002; 43 Suppl 2():37-44. PubMed ID: 11903482
[TBL] [Abstract][Full Text] [Related]
17. CYP-mediated clozapine interactions: how predictable are they?
Chetty M; Murray M
Curr Drug Metab; 2007 May; 8(4):307-13. PubMed ID: 17504220
[TBL] [Abstract][Full Text] [Related]
18. Drug interactions and antipsychotic therapy.
DeVane CL
Pharmacotherapy; 1996; 16(1 Pt 2):15-20. PubMed ID: 8778682
[TBL] [Abstract][Full Text] [Related]
19. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics.
Beunk L; Nijenhuis M; Soree B; de Boer-Veger NJ; Buunk AM; Guchelaar HJ; Houwink EJF; Risselada A; Rongen GAPJM; van Schaik RHN; Swen JJ; Touw D; van Westrhenen R; Deneer VHM; van der Weide J
Eur J Hum Genet; 2024 Mar; 32(3):278-285. PubMed ID: 37002327
[TBL] [Abstract][Full Text] [Related]
20. Drug-drug interactions associated with second-generation antipsychotics: considerations for clinicians and patients.
Conley RR; Kelly DL
Psychopharmacol Bull; 2007; 40(1):77-97. PubMed ID: 17285099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
